Website Overview: adstiladrinhcp.com
General information
Last Updated: 2024-06-29 (yyyy-mm-dd).
Title: ADSTILADRIN nadofaragene firadenovec vncg For HCP
Description: ADSTILADRIN is the first and only FDA approved intravesical gene therapy for patients with high risk BCG unresponsive NMIBC See Important Safety Info
Language: English
Company
Name Organization
- ADSTILADRIN nadofaragene firadenovec vncg
Contact information
Telephone
- 18446236669
- 18003321088
- 18883377464
Services and technology that the website used
Web Buider
- Wordpress
Related Websites
- ferringusa.com
- adstiladrin.com
- vimeo.com
- nccn.org
- ethicspointvp.com